规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | CCG-100602 is a specific inhibitor of MRTF-A/SRF signalling. CCG-100602 specifically blocks MRTF-A nuclear localisation, thereby inhibiting the fibrotic transcription factor SRF and blocking the expression of MRTF-A/SRF activated genes[1][2].At concentrations of 3-30 μM, CCG-100602 reduces the number of adherent hASC cells[2].At concentrations of 5-40 μM, CCG-100602 reduced TGF-β1 (5 mg/ml) induced COL1A1, FN1 and ACTA2 transcription in a dose-dependent manner, and also reduced TGF-β1 induced protein expression of ECM and α-SMA[1]. |
Animal study | At a dose of 7.5 mg/kg/day, administered continuously for 2 weeks by osmotic pump, CCG-100602 exhibited significant anti-stiffening effects in male spontaneously hypertensive rats (SHR) through inhibition of SRF/troponin[3]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.09mL 0.42mL 0.21mL |
10.44mL 2.09mL 1.04mL |
20.89mL 4.18mL 2.09mL |
CAS号 | 1207113-88-9 |
分子式 | C21H17ClF6N2O2 |
分子量 | 478.81 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 105 mg/mL(219.29 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |